Serratia proteamaculans and Opportunistic Hospital Infections

Serratia proteamaculans belongs to the Family Enterobacteriaceae and the Genus Serratia. It is a Gram-negative, facultatively anaerobic rod-shaped bacterium.

The organism possesses peritrichous flagella that confer active motility. A distinctive laboratory characteristic is its ability to produce a red pigment known as prodigiosin. Pigment production is most pronounced at temperatures between 25–30 °C and may decrease or disappear at 37 °C.

Historically, the appearance of red pigmentation on food or surfaces caused confusion and was sometimes interpreted as unexplained phenomena. Beyond pigmentation, the bacterium can ferment various carbohydrates and produce enzymes such as DNase, lipase, and gelatinase.

Serratia proteamaculans is widely distributed in environmental reservoirs including soil, freshwater systems, and plant surfaces. Within hospital settings, it may colonize moist surfaces such as sinks, drainage outlets, ventilator tubing, disinfectant solutions, and various liquid containers.

Its ability to survive in humid environments and persist on medical equipment enables the bacterium to establish environmental reservoirs that may contribute to healthcare-associated transmission.

Although generally harmless to healthy individuals, it can cause infection in hospitalized patients with compromised immunity or disrupted physical barriers.

Serratia proteamaculans is considered an opportunistic pathogen primarily associated with hospital-acquired infections.

• Hospital-Acquired Pneumonia: Including ventilator-associated pneumonia in critically ill patients.
• Urinary Tract Infection: Often related to indwelling urinary catheters.
• Bloodstream Infection: Frequently linked to central venous catheters and other intravascular devices.
• Surgical Site Infection and Ocular Infection: Occasionally associated with contaminated medical equipment or contact lens solutions.

Patients at highest risk include ICU patients, individuals receiving prolonged antibiotic therapy, those with invasive medical devices, premature neonates, and immunocompromised individuals.

Diagnosis relies primarily on the isolation of the organism from clinical specimens such as sputum, blood, urine, or wound exudates.

The characteristic red pigmentation of colonies may provide an initial identification clue. However, accurate species identification generally requires automated microbiological identification systems or molecular techniques.

Probe-based real-time PCR and sequencing methods provide rapid and specific detection, improving diagnostic accuracy and supporting epidemiological investigations.

Clinical management of infections caused by Serratia proteamaculans must be guided by antimicrobial susceptibility testing because the organism exhibits both intrinsic and acquired resistance mechanisms.

In addition to antimicrobial therapy, effective infection control measures are essential to limit transmission in healthcare settings.

Serratia proteamaculans exemplifies how environmental bacteria can transition into clinically significant opportunistic pathogens within healthcare environments. Its persistence in humid hospital surfaces and potential antimicrobial resistance underscore the importance of environmental hygiene and antimicrobial stewardship.

Future efforts should focus on improving diagnostic capabilities, monitoring resistance trends, and strengthening infection prevention strategies to reduce the clinical impact of this organism.